top of page
Our Team
Chiromesh Therapeutics is a U.S. early-stage biotech company, founded by global leaders in drug delivery, bioengineering and nanomedicine, cancer biology, neurosurgery, and immunotherapy
​​
Our team is committed to designing and developing drug delivery platforms that precisely deploy advanced therapies, ensuring maximum benefit for each patient
​
Chiromesh Therapeutics, Inc. is incorporated in the State of Delaware and registered to operate in the State of California
A Global Alliance
Chiromesh Therapeutics, Inc. is headquartered in Mountain View, CA, in the heart of Silicon Valley, with additional research laboratories and state-of-the-art facilities at Stanford University (CA), MD Anderson Cancer Center in Houston (TX); and the Italian Institute of Technology in Genoa (Italy)
​​µMESH is being developed by an interdisciplinary team of scientists, engineers, and physician adopting the most rigorous protocols and models
​
Chiromesh Therapeutics, Inc. benefits from its proximity to world-class research institutions and its ability to access diverse funding sources in California, Texas, the US, and Europe, which provides it with a strategic advantage
The design, development, and preclinical validation of µMESH have been supported by various governmental agencies and research foundations in Europe and North America, totaling over $3.0 million to date
bottom of page